This site is intended for healthcare professionals
Optimising anti-TNF treatment using biosimilars Learning Zone


Read time: 100 mins
Last updated:18th Nov 2022
Published:12th Feb 2020

Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.